Narrow-Band UVB Therapy and Topical Calcineurin Inhibitors for the Treatment of Paediatric Vitiligo in Real Clinical Practice
, , , , e
22 lug 2021
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 22 lug 2021
Pagine: 200 - 205
Ricevuto: 15 lug 2020
Accettato: 24 gen 2021
DOI: https://doi.org/10.2478/prolas-2021-0029
Parole chiave
© 2020 Ilona Hartmane et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hartmane, Ilona
Clinical Centre of Skin and Sexually Transmitted Diseases, Rīga 1st HospitalLatvia
Department of Dermatology and Venerology, Rīga Stradiņš UniversityLatvia
Mikažāns, Ingmārs
Clinical Centre of Skin and Sexually Transmitted Diseases, Rīga 1st HospitalLatvia
Department of Dermatology and Venerology, Rīga Stradiņš UniversityLatvia
Ivdra, Iveta
Clinical Centre of Skin and Sexually Transmitted Diseases, Rīga 1st HospitalLatvia
Department of Dermatology and Venerology, Rīga Stradiņš UniversityLatvia
Mirzajanova, Irēna
Department of Pharmacology, Rīga Stradiņš UniversityLatvia
UAB Johnson & Johnson Latvian branchLatvia
Dērveniece, Andra
Clinical Centre of Skin and Sexually Transmitted Diseases, Rīga 1st HospitalLatvia
Department of Dermatology and Venerology, Rīga Stradiņš UniversityLatvia
Bondare-Ansberga, Vanda
Clinical Centre of Skin and Sexually Transmitted Diseases, Rīga 1st HospitalLatvia